Affiliation:
1. Department of Nervous System Diseases and Neurosurgery N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
2. Department of Clinical Pharmacology and Internal Diseases Propaedeutics, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia; Department of therapy and polymorbid pathology, Russian Medical Academy of Continuous Professional Education, Ministry of Health of Russia
Abstract
Drug-induced tremor (DIT) is a term used to describe tremors that develop or increase in severity due to various medications administration. As multiple drugs are associated with DIT it is quite common in clinical practice and medication dose is frequently associated with tremor severity. DIT is associated with commonly prescribed drugs such as amiodarone, antidepressants, β-agonists, cyclosporine, lithium, tacrolimus and valproic acid. DIT mechanisms include dopamine receptors block, gamma-aminobutyric acid depletion, cholinergic deficiency. DIT risk factors include older age, female sex, longer administration of drugs associated with tremor or/and their administration in higher doses, history of tremor in the patient and/or relatives, excessive caffeine intake. It is necessary to establish a causal relationship between the use of a potential inducer drug and the development/intensification of tremor to diagnose DIT. If DIT is detected, the inducer drug should be discontinued or its dose reduced. To decrease DIT risk, it is recommended to avoid prescribing drugs which are most commonly associated with DIT.
Subject
Psychiatry and Mental health,Neurology (clinical),Clinical Psychology
Reference39 articles.
1. Kamble N, Pal PK. Tremor syndromes: A review. Neurol India. Mar-Apr 2018;66(Supplement):S36-S47. doi: 10.4103/0028-3886.226440
2. Morgan JC, Sethi KD. Drug-induced tremors. Lancet Neurol. 2005 Dec;4(12):866-76. doi: 10.1016/S1474-4422(05)70250-7
3. Tisdale JE, Miller DA, eds. Drug-induced diseases: prevention, detection, and management. 3rd ed. Bethesda, Md: American Society of Health-System Pharmacists; 2018. 1400 p.
4. Martino D, Karnik V, Osland S, et al. Movement disorders associated with antipsychotic medication in people with schizophrenia: an overview of Cochrane reviews and metaanalysis. Can J Psychiatry. 2018 Jan;63(11):706743718777392. doi: 10.1177/0706743718777392
5. Morgan JC, Kurek JA, Davis JL, Sethi KD. Insights into pathophysiology from medicationinduced tremor. Tremor Other Hyperkinet Mov (N Y). 2017 Nov22;7:442. doi: 10.7916/D8FJ2V9Q. eCollection 2017.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献